CASTLE BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Description as filed by funds: To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: Kimberlee S. Caple

CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: Kimberlee S. Caple”): 13,580,035 for, 7,764,145 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Election of Directors The Company's stockholders elected the three individuals listed below as Class III Directors, each to serve until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 64% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 65 managers: 7,286,182 for, 2,777,128 withheld, 25,732 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 1 managers: 114,008 withheld.

Description as filed by funds: To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: G. Bradley Cole

CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: G. Bradley Cole”): 19,839,019 for, 1,505,161 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Election of Directors The Company's stockholders elected the three individuals listed below as Class III Directors, each to serve until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 64 managers: 9,009,157 for, 1,090,265 withheld, 8,217 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 1 managers: 114,008 for.

Description as filed by funds: DIRECTOR: DEREK MAETZOLD

CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: Derek J. Maetzold”): 19,909,583 for, 1,434,597 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Election of Directors The Company's stockholders elected the three individuals listed below as Class III Directors, each to serve until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 26 asset managers below reported 2,386,880 for, 5,063 withheld, 8,217 abstained.

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

Description as filed by funds: To approve the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company to the maximum extent permitted by Delaware law.

CASTLE BIOSCIENCES INC.’s own tally for this item (“4. Approval of Amendment and Restatement of the Company's Amended and Restated Certificate of Incorporation”): 20,327,249 for, 976,000 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the A&R Charter to limit the liability of certain officers of the company to the maximum extent permitted by the DGCL.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 65 managers: 9,882,181 for, 181,309 against, 26,063 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 2 managers: 115,939 for.

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.

CASTLE BIOSCIENCES INC.’s own tally for this item (“3. Approval of the Compensation of the Company's Named Executive Officers”): 19,986,768 for, 1,314,254 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Approval of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 66 managers: 10,094,130 for, 26,063 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 171 managers: 12,633,281 for, 766,155 against. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

CASTLE BIOSCIENCES INC.’s own tally for this item (“2. Ratification of the Selection of Independent Registered Public Accounting Firm”): 23,690,098 for, 20,837 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection of KPMG LLP by the Audit Committee of the Company's Board of Directors as the Company's independent registered public accounting firm for the fiscal year ending December …”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 65 managers: 10,084,155 for, 335 against, 5,063 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 2 managers: 115,939 for.